John Gnann to Risk Factors
This is a "connection" page, showing publications John Gnann has written about Risk Factors.
Connection Strength
0.106
-
Herpes zoster in the age of focused immunosuppressive therapy. JAMA. 2009 Feb 18; 301(7):774-5.
Score: 0.040
-
Risk factors for mortality and progression to severe COVID-19 disease in the Southeast region in the United States: A report from the SEUS Study Group. Infect Control Hosp Epidemiol. 2021 12; 42(12):1464-1472.
Score: 0.023
-
Herpes zoster: risk categories for persistent pain. J Infect Dis. 1999 Jan; 179(1):9-15.
Score: 0.020
-
Herpes simplex encephalitis during treatment with tumor necrosis factor-alpha inhibitors. Clin Infect Dis. 2009 Sep 15; 49(6):924-7.
Score: 0.010
-
The epidemiological, clinical, and pathological rationale for the herpes zoster vaccine. J Infect Dis. 2008 Mar 01; 197 Suppl 2:S207-15.
Score: 0.009
-
A mixed model for factors predictive of pain in AIDS patients with herpes zoster. J Pain Symptom Manage. 1999 Jun; 17(6):410-7.
Score: 0.005